STAGE IIIC1 CERVICAL CANCER FIGO 2018

Clinical trials for STAGE IIIC1 CERVICAL CANCER FIGO 2018 explained in plain language.

Never miss a new study

Get alerted when new STAGE IIIC1 CERVICAL CANCER FIGO 2018 trials appear

Sign up with your email to follow new studies for STAGE IIIC1 CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New trial tests aggressive combo therapy to fight tough cervical cancers

Disease control Recruiting now

This study is for people with cervical cancer that has spread to nearby tissues or lymph nodes. It compares two treatment plans that combine chemotherapy, radiation, and an immunotherapy drug called pembrolizumab. One plan adds extra chemotherapy and immunotherapy at the start. T…

Matched conditions: STAGE IIIC1 CERVICAL CANCER FIGO 2018

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

STAGE IIIC1 CERVICAL CANCER FIGO 2018

Get alerted when new STAGE IIIC1 CERVICAL CANCER FIGO 2018 trials appear

New trial tests aggressive combo therapy to fight tough cervical cancers